High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: Phase I trial in combination with vinblastine

Donald L. Trump, David C. Smith, Peter G. Ellis, Miriam P. Rogers, S. Clifford Schold, Eric P. Winer, Timothy J. Panella, V. Craig Jordan, Robert L. Fine

Research output: Contribution to journal › Article › peer-review